Associated Papers
Pharmacogenomics and chronotherapy of drug-induced cardioprotection in acute myocardial infarction.
Clemente-Moragón A et al.
Nature Communications, 2025
The role of the ADRB2 Thr164Ile variant in lung function determination, plasma proteome variability and other phenotypes in UK Biobank.
Fawcett KA et al.
Erj Open Research, 2025
Exploring the role of β2- and β3-adrenergic receptors in cystic fibrosis.
Cannavo A et al.
Pulmonary Pharmacology & Therapeutics, 2025
In vitro evaluation of promiscuity and toxicity of a small molecule targeting wild and T164I β2-adrenergic receptors.
Bandaru S et al.
Bioorganic Chemistry, 2024
Association between the rs12654778 SNP of the β-2 adrenergic receptor and LDL cholesterol levels in the Chilean adult population.
González-Contreras C et al.
Endocrinologia, Diabetes Y Nutricion, 2024
The Role of Single Nucleotide Polymorphisms in Beta-2 Adrenergic Receptors in the Severity of Obstructive Sleep Apnea Syndrome in Pediatric Patients.
Ferrari M et al.
Cureus, 2024
ADRB2 and ADCY9 Sequence Variations in Brazilian Asthmatic Patients.
Silva VDC et al.
Current Issues in Molecular Biology, 2024
Meta-analysis of genomic variants in power and endurance sports to decode the impact of genomics on athletic performance and success.
Psatha A et al.
Human Genomics, 2024
Evaluation of ADRB2 and OATP2A1 genetic polymorphisms in Indian patients with primary open-angle glaucoma.
Gowtham L et al.
Pharmacogenetics and Genomics, 2024
Genetic Variants of Adrenoceptors.
Ahles A et al.
Handbook of Experimental Pharmacology, 2024
Integration of genetic fine-mapping and multi-omics data reveals candidate effector genes for hypertension.
van Duijvenboden S et al.
American Journal of Human Genetics, 2023
Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
Álvarez-Prado ÁF et al.
Cell Reports. Medicine, 2023
Association between the Ile164 β2 Adrenergic Receptor Polymorphism and Fatigue in Patients with Rheumatoid Arthritis.
Philipp J et al.
Neuroimmunomodulation, 2023
Immunogenetics and pharmacogenetics of allergic asthma in Africa.
Mabelane T et al.
Frontiers in Allergy, 2023
Somatic Double Inactivation of NF1 Associated with NF1-Related Pectus Excavatum Deformity.
Chelleri C et al.
Human Mutation, 2023
A novel thymidine phosphorylase mutation in a family with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): Molecular docking, dynamic simulation and computational investigations.
Ammar M et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience, 2022
Pharmacogenetics may explain part of the interindividual variability of dobutamine pharmacodynamics in neonates.
Hallik M et al.
British Journal of Clinical Pharmacology, 2022
Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD?
Park SS et al.
Medicina (kaunas, Lithuania), 2022
Recent advances in pharmacogenomics research of anti-asthmatic drugs: a narrative review.
Li J et al.
Annals of Translational Medicine, 2022
Measuring Pharmacogene Variant Function at Scale Using Multiplexed Assays.
Geck RC et al.
Annual Review of Pharmacology and Toxicology, 2022
Association between beta-2 adrenergic receptor variants and clinical outcomes in children and adolescents with acute asthma.
Muchão FP et al.
Einstein (sao Paulo, Brazil), 2022
SARS-CoV-2 Mutations and COVID-19 Clinical Outcome: Mutation Global Frequency Dynamics and Structural Modulation Hold the Key.
Maurya R et al.
Frontiers in Cellular and Infection Microbiology, 2022
Association of β2-Agonist Receptor Gene Polymorphisms with Acute Exacerbations of COPD: A Prospective Observational Study.
Lu F et al.
Emergency Medicine International, 2022
Pharmacogenetic polymorphisms affecting bisoprolol response.
Castaño-Amores C et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2021
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine.
Zhou Y et al.
Science Advances, 2021
Ligand-specific pharmacogenetic effects of nonsynonymous mutations.
Morningstar-Kywi N et al.
Pharmacogenetics and Genomics, 2021
Genetic Determinants of Poor Response to Treatment in Severe Asthma.
Figueiredo RG et al.
International Journal of Molecular Sciences, 2021
Identification of Genetic Variants in 65 Obesity Related Genes in a Cohort of Portuguese Obese Individuals.
Ginete C et al.
Genes, 2021
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM et al.
Saudi Journal of Biological Sciences, 2021
Influence of rs1042713 and rs1042714 polymorphisms of β2-adrenergic receptor gene with erythrocyte cAMP in sickle cell disease patients from Odisha State, India.
Sinha S et al.
Annals of Hematology, 2020
Hereditary Haemorrhagic Telangiectasia (HHT) Marked by ACVRL1C1120T Variant Displays Hypopigmented Naevi and Frequent Bleeding Episodes if CYP2C9 Co-Mutated: Clinical Notes & Rationale of Patient Registry.
Minarik L et al.
Folia Biologica, 2020
Differential Dynamics Underlying the Gln27Glu Population Variant of the β2-Adrenergic Receptor.
Bhosale S et al.
The Journal of Membrane Biology, 2019
Dissecting genetic factors affecting phenylephrine infusion rates during anesthesia: a genome-wide association study employing EHR data.
Zhang Y et al.
Bmc Medicine, 2019
Targeted next generation sequencing as a tool for precision medicine.
Gulilat M et al.
Bmc Medical Genomics, 2019
Role of THRB, ARG1, and ADRB2 Genetic Variants on Bronchodilators Response in Asthmatic Children.
Scaparrotta A et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2019
Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
Zhang C et al.
Molecular Genetics & Genomic Medicine, 2019
Correlation study on β2-adrenergic receptor gene polymorphisms and asthma susceptibility: evidence based on 57 case-control studies.
Yu X et al.
European Review for Medical and Pharmacological Sciences, 2019
β2-Adrenergic Receptor Gene Polymorphisms Are Associated with Cardiovascular Events But not All-Cause Mortality in Coronary Artery Disease Patients: A Meta-Analysis of Prospective Studies.
Li Y et al.
Genetic Testing and Molecular Biomarkers, 2019
Cardiovascular Pharmacogenomics: Does It Matter If You're Black or White?
De T et al.
Annual Review of Pharmacology and Toxicology, 2019
Association of genetic variants with level of asthma control in the Arab population.
Almomani BA et al.
Journal of Asthma and Allergy, 2019
Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics.
John SE et al.
Scientific Reports, 2018
ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure.
Huang J et al.
Cell Discovery, 2018
Association between ß2-adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study.
Chung JE et al.
Bmc Genetics, 2017